Incidence of Guillain-Barre syndrome following infection with Campylobacter jejuni

被引:125
作者
McCarthy, N
Giesecke, J
机构
[1] Swedish Inst Infect Dis Control, SE-17182 Solna, Sweden
[2] European Union, European Commiss, European Programme Intervent Epidemiol Training, Brussels, Belgium
[3] Karolinska Inst, SE-17177 Solna, Sweden
关键词
Campylobacter infections; Campylobacter jejuni; incidence; polyradiculoneuritis;
D O I
10.1093/aje/153.6.610
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Evidence of recent or ongoing Campylobacter jejuni infection has been found in approximately one out of every four cases of Guiltain-Barre syndrome (GBS). It is increasingly accepted that C. jejuni infection is an important causal factor for GBS. However, the likelihood of GBS' occurring following an episode of C. jejuni gastroenteritis has not been measured. The authors measured the incidence of GBS in a large cohort of persons with laboratory-confirmed C. jejuni infection. Cases of C. jejuni infection were derived from the Swedish national laboratory reporting system for the years 198f-1995. Follow-up for GBS was carried out using the Swedish national hospital inpatient register. Nine cases of GBS were detected in the cohort, which comprised 29,563 cases of C. jejuni infection-a rate of 30.4 per 100,000 (95% confidence interval: 13.9, 57.8). This compares with an expected incidence of 0.3 per 100,000 in a g-month period in the general population. GBS is an important but rare complication of C. jejuni infection. The risk of developing GBS during the 2 months following a symptomatic episode of C. jejuni infection is approximately 100 times higher than the risk in the general population.
引用
收藏
页码:610 / 614
页数:5
相关论文
共 24 条
[1]   Association between Campylobacter infection and Guillain-Barre syndrome [J].
Allos, BM .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 :S125-S128
[2]   The economic burden of Campylobacter-associated Guillain-Barre syndrome [J].
Buzby, JC ;
Allos, BM ;
Roberts, T .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 :S192-S197
[3]  
CHALKER RB, 1988, REV INFECT DIS, V10, P111
[4]   THE SPECTRUM OF IMMUNE-RESPONSES TO CAMPYLOBACTER-JEJUNI AND GLYCOCONJUGATES IN GUILLAIN-BARRE-SYNDROME AND IN OTHER NEUROIMMUNOLOGICAL DISORDERS [J].
ENDERS, U ;
KARCH, H ;
TOYKA, KV ;
MICHELS, M ;
ZIELASEK, J ;
PETTE, M ;
HEESEMANN, J ;
HARTUNG, HP .
ANNALS OF NEUROLOGY, 1993, 34 (02) :136-144
[5]  
*EP DEP SWED I INF, 1996, ANN REP 1995
[6]   SPECIFIC SEROTYPE OF CAMPYLOBACTER-JEJUNI ASSOCIATED WITH GUILLAIN-BARRE-SYNDROME [J].
FUJIMOTO, S ;
YUKI, N ;
ITOH, T ;
AMAKO, K .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (01) :183-183
[7]   GUILLAIN-BARRE-SYNDROME IN NORTHERN CHINA - RELATIONSHIP TO CAMPYLOBACTER-JEJUNI INFECTION AND ANTI-GLYCOLIPID ANTIBODIES [J].
HO, TW ;
MISHU, B ;
LI, CY ;
GAO, CY ;
CORNBLATH, DR ;
GRIFFIN, JW ;
ASBURY, AK ;
BLASER, MJ ;
MCKHANN, GM .
BRAIN, 1995, 118 :597-605
[8]  
JIANG GX, 1995, ACTA NEUROL SCAND, V91, P109
[9]   Epidemiological features of Guillain-Barre syndrome in Sweden, 1978-93 [J].
Jiang, GX ;
Cheng, Q ;
Link, H ;
dePedroCuesta, J .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 62 (05) :447-453
[10]  
JIANG GX, 1996, THESIS KAROLINSKA I